Ownership history in KBC Group NV Β· 71 quarters on record
This page tracks every 13F SEC filing in which KBC Group NV reported a position in ABBOTT LABS COM (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π KBC Group NV outperformed the S&P 500 by +0.1% annually on this ABT position. Timing score: 40% (27/68 decisions correct). Average cost basis: $73.62. Maximum drawdown during holding period: β30.4%.
β‘οΈ Roughly in line with S&P 500 (Β±1% alpha range).
70 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
27 of 68 add/trim decisions correct
Best entry: $15.56 (2009 Q2) Β· Worst: $134.12 (2025 Q2)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
34 adds Β· 35 trims. Bought during 13 of 27 down-price quarters. π Predominantly trimming β distribution phase.
π KBC Group NV has been actively increasing its ABT allocation β a bullish signal from insiders.
Currently 0.98% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size